Prevention of lymphocele or seroma after mastectomy and axillary lymphadenectomy for breast cancer: systematic review and meta-analysis.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
15 06 2022
Historique:
received: 20 12 2021
accepted: 30 05 2022
entrez: 15 6 2022
pubmed: 16 6 2022
medline: 18 6 2022
Statut: epublish

Résumé

Seroma or lymphocele remains the most common complication after mastectomy and lymphadenectomy for breast cancer. Many different techniques are available to prevent this complication: wound drainage, reduction of the dead space by flap fixation, use of various types of energy, external compression dressings, shoulder immobilization or physical activity, as well as numerous drugs and glues. We searched MEDLINE, clinicaltrials.gov, Cochrane Library, and Web of Science databases for publications addressing the issue of prevention of lymphocele or seroma after mastectomy and axillary lymphadenectomy. Quality was assessed using Hawker's quality assessment tool. Incidence of seroma or lymphocele were collected. Fifteen randomized controlled trials including a total of 1766 patients undergoing radical mastectomy and axillary lymphadenectomy for breast cancer were retrieved. The incidence of lymphocele or seroma in the study population was 24.2% (411/1698): 25.2% (232/920) in the test groups and 23.0% (179/778) in the control groups. Neither modification of surgical technique (RR 0.86; 95% CI [0.72, 1.03]) nor application of a medical treatment (RR 0.96; 95% CI [0.72, 1.29]) was effective in preventing lymphocele. On the contrary, decreasing the drainage time increased the risk of lymphocele (RR 1.88; 95% CI [1.43, 2.48). There was no publication bias but the studies were of medium to low quality. To conclude, despite the heterogeneity of study designs, drainage appears to be the most effective technique, although the overall quality of the data is low.

Identifiants

pubmed: 35705655
doi: 10.1038/s41598-022-13831-9
pii: 10.1038/s41598-022-13831-9
pmc: PMC9200791
doi:

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

10016

Informations de copyright

© 2022. The Author(s).

Références

Control Clin Trials. 1986 Sep;7(3):177-88
pubmed: 3802833
Ann Surg. 1999 Aug;230(2):194-201
pubmed: 10450733
BMC Cancer. 2019 Jan 23;19(1):99
pubmed: 30674296
Changgeng Yi Xue Za Zhi. 1999 Mar;22(1):37-43
pubmed: 10418208
Cochrane Database Syst Rev. 2013 Oct 20;(10):CD006823
pubmed: 24158902
Breast. 2019 Aug;46:81-86
pubmed: 31103811
J Surg Oncol. 2000 Apr;73(4):224-7
pubmed: 10797336
BMJ. 1997 Sep 13;315(7109):629-34
pubmed: 9310563
J Invest Surg. 2017 Feb;30(1):1-5
pubmed: 27431576
Breast Cancer Res Treat. 2013 Nov;142(2):399-404
pubmed: 24186056
East Afr Med J. 2007 Dec;84(12):561-5
pubmed: 18402307
Am J Surg. 1999 Jun;177(6):450-3
pubmed: 10414691
Int J Surg. 2013;11(6):496-500
pubmed: 23579255
Cochrane Database Syst Rev. 2013 May 31;(5):CD009557
pubmed: 23728694
Breast J. 2003 Sep-Oct;9(5):393-6
pubmed: 12968960
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
BMJ Open. 2016 Apr 04;6(4):e009903
pubmed: 27044574
Stat Med. 1987 Apr-May;6(3):341-50
pubmed: 3616287
Qual Health Res. 2002 Nov;12(9):1284-99
pubmed: 12448672
PLoS One. 2016 Jun 09;11(6):e0156096
pubmed: 27280398
Jpn J Clin Oncol. 2006 Apr;36(4):197-206
pubmed: 16684859
Breast. 2000 Jun;9(3):144-8
pubmed: 14731838
Am J Surg. 2010 Sep;200(3):352-6
pubmed: 20409509
Rev Invest Clin. 2015 Nov-Dec;67(6):357-65
pubmed: 26950740
World J Surg. 2013 Jan;37(1):59-66
pubmed: 23052809
Eur J Surg Oncol. 2001 Feb;27(1):26-30
pubmed: 11237488
Physiother Theory Pract. 2014 Aug;30(6):384-9
pubmed: 24410411
Int J Surg. 2014 Nov;12(11):1210-5
pubmed: 25462702
Eur J Surg Oncol. 2004 Aug;30(6):602-9
pubmed: 15256232
J Ayub Med Coll Abbottabad. 2017 Apr-Jun;29(2):207-210
pubmed: 28718232
BMC Cancer. 2005 Jan 27;5:11
pubmed: 15676064
South Surg. 1947 Jun;13(6):372-5
pubmed: 20243783
BMJ. 2011 Oct 18;343:d5928
pubmed: 22008217
Surg Infect (Larchmt). 2013 Jun;14(3):244-69
pubmed: 23718273
Ann Surg Oncol. 2014 Mar;21(3):808-14
pubmed: 24232511
Eur J Surg Oncol. 2012 Oct;38(10):902-9
pubmed: 22703757
J Clin Oncol. 2007 Aug 20;25(24):3657-63
pubmed: 17485711

Auteurs

Crestani Adrien (C)

Institut Curie, 35, Rue Dailly, 92210, Saint-Cloud, France.

Mahiou Katia (M)

Institut Curie, 35, Rue Dailly, 92210, Saint-Cloud, France.

Bodet Marie-Lucile (B)

Institut Curie, 35, Rue Dailly, 92210, Saint-Cloud, France.

Roosen Alice (R)

Institut Curie, 35, Rue Dailly, 92210, Saint-Cloud, France.

Bonneau Claire (B)

Institut Curie, 35, Rue Dailly, 92210, Saint-Cloud, France.

Rouzier Roman (R)

Institut Curie, 35, Rue Dailly, 92210, Saint-Cloud, France. adriencrestani@hotmail.fr.
Université de Versailles SQY, Université Paris Saclay, UFR des Sciences de la Santé Simone-Veil, Paris, France. adriencrestani@hotmail.fr.
Institut Curie, Inserm U900, Saint-Cloud, France. adriencrestani@hotmail.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH